Low-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Recruiting

Low-Dose NaltrexoneLow-Dose Naltrexone for the Treatment of Complex Regional Pain Syndrome

Sponsor:

Stanford University

Code:

NCT02502162

Conditions

Complex Regional Pain Syndrome

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

LDN

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-24. This information was provided to ClinicalTrials.gov by Stanford University on 2024-12-02.